Related Experiment Video
Updated: Jun 21, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
CA-074Me protection against anthrax lethal toxin
Zachary L Newman1, Stephen H Leppla, Mahtab Moayeri
1Bacterial Toxins and Therapeutics Section, Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
Anthrax lethal toxin (LT) activates the NLRP1b (NALP1b) inflammasome and caspase-1 in macrophages from certain inbred mouse strains, but the mechanism by which this occurs is poorly understood. We report here that similar to several NLRP3 (NALP3, cryopyrin)-activating stimuli, LT activation of the NLRP1b inflammasome involves lysosomal membrane permeabilization (LMP) and subsequent cytoplasmic cathepsin B activity. CA-074Me, a potent cathepsin B inhibitor, protects LT-sensitive macrophages from cell death and prevents the activation of caspase-1. RNA interference knockdown of cathepsin B expression, however, cannot prevent LT-mediated cell death, suggesting that CA-074Me may also act on other cellular proteases released during LMP. CA-074Me appears to function downstream of LT translocation to the cytosol (as assessed by mitogen-activated protein kinase kinase cleavage), K(+) effluxes, and proteasome activity. The initial increase in cytoplasmic activity of cathepsin B occurs at the same time or shortly before caspase-1 activation but precedes a larger-scale lysosomal destabilization correlated closely with cytolysis. We present results suggesting that LMP may be involved in the activation of the NLRP1b inflammasome.
Insights
Anthrax lethal toxin (LT) triggers the NLRP1b inflammasome via lysosomal membrane permeabilization and cathepsin B activity. This process is crucial for macrophage cell death and caspase-1 activation.
Area of Science:
- Immunology
- Cell Biology
- Toxicology
Background:
- Anthrax lethal toxin (LT) activates the NLRP1b inflammasome and caspase-1 in macrophages, but the precise mechanism remains unclear.
- Lysosomal membrane permeabilization (LMP) and cathepsin B activity are implicated in inflammasome activation by other stimuli.
Purpose of the Study:
- To elucidate the role of lysosomal membrane permeabilization and cathepsin B in LT-induced NLRP1b inflammasome activation.
- To investigate the mechanism by which LT activates the NLRP1b inflammasome in macrophages.
Main Methods:
- Utilized CA-074Me, a cathepsin B inhibitor, and RNA interference for cathepsin B knockdown.
- Assessed LT translocation, potassium efflux, proteasome activity, and caspase-1 activation.
- Monitored lysosomal membrane permeabilization and cathepsin B cytoplasmic activity.
Main Results:
- LT-induced NLRP1b inflammasome activation involves lysosomal membrane permeabilization and subsequent cathepsin B activity.
- CA-074Me protected macrophages from LT-induced cell death and inhibited caspase-1 activation.
- Cathepsin B knockdown did not prevent cell death, suggesting CA-074Me acts on other proteases.
- CA-074Me acted downstream of LT translocation, K(+) efflux, and proteasome activity.
Conclusions:
- Lysosomal membrane permeabilization and cathepsin B activity are key events in LT-mediated NLRP1b inflammasome activation.
- CA-074Me's protective effect suggests a broader role in inhibiting proteases released during LMP.
- LMP is likely involved in the initial activation of the NLRP1b inflammasome by anthrax lethal toxin.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
09:30Analyzing Dynamic Protein Complexes Assembled On and Released From Biolayer Interferometry Biosensor Using Mass Spectrometry and Electron Microscopy
Published on: August 6, 2018
Related Concept Videos
Inhalation Anthrax
Clinical Significance of Antibiotic Resistance
Diphtheria
Bacterial Toxins